These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

985 related items for PubMed ID: 9713560

  • 1. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [Abstract] [Full Text] [Related]

  • 2. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair JC, Camacho-Hübner C, Miraki Moud F, Rosberg S, Burren C, Lim S, Clayton PE, Bjarnason R, Albertsson-Wikland K, Savage MO.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK, Price DA, Gill MS, Whatmore AJ, Addison GM, Clayton PE.
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [Abstract] [Full Text] [Related]

  • 4. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [Abstract] [Full Text] [Related]

  • 5. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S, Tondinelli T, Spadoni GL, Scirè G, Boemi S, Boscherini B.
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [Abstract] [Full Text] [Related]

  • 6. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia.
    Soliman AT, El Banna N, Ansari BM.
    Eur J Endocrinol; 1998 Apr; 138(4):394-400. PubMed ID: 9578506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL.
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM, Camacho-Hübner C, Holly JM, Savage MO.
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [Abstract] [Full Text] [Related]

  • 13. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M, Barreca A, Ventura M, Tinelli C, Ponzani P, De Giacomo C, Maggiore G, Severi F.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [Abstract] [Full Text] [Related]

  • 14. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P.
    Acta Paediatr Suppl; 1994 Apr; 399():117-24. PubMed ID: 7949595
    [Abstract] [Full Text] [Related]

  • 15. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM, Julius JR, Stoppani C, Rundle AC.
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [Abstract] [Full Text] [Related]

  • 16. Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome?
    Rakover Y, Silbergeld A, Lavi I, Masalha R, Shlomo IB.
    Eur J Endocrinol; 2002 Mar; 146(3):319-23. PubMed ID: 11888837
    [Abstract] [Full Text] [Related]

  • 17. Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature.
    Imamoğlu S, Bereket A, Turan S, Taga Y, Haklar G.
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):69-74. PubMed ID: 15679071
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.
    Gill MS, Whatmore AJ, Tillman V, White A, Addison GM, Price DA, Clayton PE.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):483-92. PubMed ID: 9196612
    [Abstract] [Full Text] [Related]

  • 20. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment.
    Low LC, Postel-Vinay MC, Kwan EY, Cheung PT.
    Clin Endocrinol (Oxf); 1998 May; 48(5):641-6. PubMed ID: 9666877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.